Last updated: January 30, 2022
Sponsor: Agence Sanitaire et Sociale de Nouvelle Calédonie
Overall Status: Suspended
Phase
N/A
Condition
Hypercholesterolemia
Diabetic Neuropathy
Diabetic Kidney Disease
Treatment
N/AClinical Study ID
NCT05218304
2021-A01260-41
Ages 18-64 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individuals informed of the conduct of the research and having given their writtenconsent to participate in the study (questionnaire and taking physical measurements);
- Individuals between the ages of 18 and 64;
- Individuals residing in New Caledonia in so-called "ordinary" housing under their mainresidence at the last population census in 2019;
Exclusion
Exclusion Criteria:
- Pregnant or breastfeeding women;
- Tourists and transients staying in New Caledonia for less than 6 months at the time ofthe investigation;
- People who are not intellectually fit to answer the questionnaire;
- Persons subject to guardianship, curatorship or any other legal incapacity;
- For the second phase of the study will be excluded people describing a febrilesyndrome;
Study Design
Total Participants: 5471
Study Start date:
July 26, 2021
Estimated Completion Date:
May 30, 2022
Study Description
Connect with a study center
Agence Sanitaire et Sociale Nouvelle Calédonie
Nouméa, 98800
New CaledoniaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.